Is Small Intestine Bacterial Overgrowth (SIBO) contagious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is SIBO Contagious?

No, Small Intestinal Bacterial Overgrowth (SIBO) is not contagious and cannot be transmitted from person to person. 1

Why SIBO Is Not Transmissible

SIBO develops from an overgrowth of bacteria that are already present in your own gastrointestinal tract, not from external pathogens. 2, 3 The condition arises when protective mechanisms that normally prevent bacterial colonization of the small intestine fail, allowing your own intestinal bacteria to proliferate excessively in the wrong location. 4

Key Distinguishing Features

  • SIBO is not an infection - It represents dysbiosis (bacterial imbalance) rather than invasion by foreign infectious organisms. 5
  • In controlled studies, no healthy controls tested positive for SIBO, demonstrating it requires underlying predisposing factors rather than exposure to affected individuals. 1
  • Unlike true GI infections (C. difficile, CMV, HSV), SIBO does not require isolation precautions or contact avoidance. 1

What Actually Causes SIBO

SIBO develops when normal protective mechanisms break down:

Primary Mechanisms

  • Impaired migrating myoelectric complex (MMC) prevents proper clearance of intestinal debris, creating gut stasis that allows bacterial proliferation. 6, 7
  • Reduced gastric acid (often from proton pump inhibitors) eliminates the normal acid barrier against bacterial overgrowth. 7, 3
  • Incompetent ileocecal valve allows colonic bacteria to reflux backward into the small intestine. 1, 7
  • Altered intestinal motility from conditions like diabetes with autonomic neuropathy, medications (opioids, anticholinergics), or surgical changes. 7, 3

Structural and Metabolic Factors

  • Prior abdominal surgery, particularly resection of the ileocecal valve or procedures altering normal anatomy. 1, 7
  • Pancreatic insufficiency reduces bacteriostatic pancreatic secretions, occurring in up to 92% of chronic pancreatitis patients with exocrine insufficiency. 1, 7
  • Impaired local intestinal immunity affecting immunoglobulin secretion. 7

Clinical Implications

Common pitfall: Patients and providers sometimes confuse SIBO with infectious gastroenteritis because symptoms overlap (diarrhea, bloating, abdominal pain). 2, 3 However, the management is entirely different - SIBO requires addressing underlying motility or anatomic issues plus antibiotic therapy (typically rifaximin 550mg twice daily for 1-2 weeks), not isolation or infection control measures. 6, 8, 3

Important distinction: While SIBO itself is not contagious, true GI infections that may occur in immunosuppressed patients (bacterial, viral, fungal) ARE transmissible and require appropriate precautions. 1 If a patient presents with acute diarrhea, stool analysis should be performed to exclude infectious causes before attributing symptoms solely to SIBO. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Small intestinal bacterial overgrowth: a comprehensive review.

Gastroenterology & hepatology, 2007

Research

Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.

Clinical and translational gastroenterology, 2019

Research

Small intestinal bacterial overgrowth: diagnosis and treatment.

Digestive diseases (Basel, Switzerland), 2007

Guideline

Mechanisms of Untreated Methane-Dominant SIBO and Hashimoto's Flareup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Causas y Mecanismos del Sobrecrecimiento Bacteriano del Intestino Delgado (SIBO)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dietary Management of Small Intestinal Bacterial Overgrowth (SIBO)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.